結(jié)核性胸膜炎治療研究進(jìn)展
發(fā)布時(shí)間:2018-03-07 09:10
本文選題:結(jié)核性胸膜炎 切入點(diǎn):治療 出處:《職業(yè)與健康》2016年08期 論文類型:期刊論文
【摘要】:結(jié)核性胸膜炎是結(jié)核分枝桿菌引起的胸膜炎癥病變。由于發(fā)現(xiàn)晚,治療不及時(shí)等原因常導(dǎo)致胸膜粘連、包裹、肥厚,造成患者限制性肺通氣功能障礙,早期發(fā)現(xiàn)并全身抗結(jié)核化療是減少病情惡化及并發(fā)癥的關(guān)鍵,在治療過程中多采用穿刺抽液留置中心靜脈導(dǎo)管微創(chuàng)引流術(shù),胸腔灌洗、免疫、中西醫(yī)結(jié)合治療等方法,作者參考近期國內(nèi)外文獻(xiàn)對常規(guī)治療方法和藥物、免疫治療和中西醫(yī)結(jié)合治療3個(gè)方面進(jìn)行綜述。
[Abstract]:Tuberculous pleurisy is a disease of pleuritis caused by Mycobacterium tuberculosis. Due to late discovery and late treatment, it often leads to pleural adhesion, encapsulation and hypertrophy, resulting in restricted pulmonary ventilation dysfunction. Early detection and systemic antituberculous chemotherapy are the key to reduce the deterioration and complications of the disease. In the course of treatment, the central venous catheter drainage, thoracic lavage, immunization and integrated Chinese and western medicine are often used in the course of treatment, such as minimally invasive drainage, thoracic lavage, immunization, and combination of traditional Chinese and western medicine, etc. The author reviewed the three aspects of routine treatment and medicine, immunotherapy and integrated Chinese and western medicine therapy with reference to recent literature at home and abroad.
【作者單位】: 天津市濱海新區(qū)漢沽疾病預(yù)防控制中心;
【分類號】:R521.7
【相似文獻(xiàn)】
相關(guān)期刊論文 前3條
1 安慧茹;王仲元;劉琳;李凈;王濤;;脊髓型結(jié)核性腦膜炎8例臨床分析[J];實(shí)用醫(yī)學(xué)雜志;2008年12期
2 陸明;;治結(jié)核,用不用激素[J];家庭醫(yī)藥;2013年12期
3 ;[J];;年期
,本文編號:1578792
本文鏈接:http://sikaile.net/yixuelunwen/chuanranbingxuelunwen/1578792.html
最近更新
教材專著